Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions

Jessica Chu, Hong Shen, Linna Wang et al.|Pharmaceutical Research|2023

Cited by 7